Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-021-01007-1, published online 30 August 2021.
In the version of this article initially published, there were errors in the numbers shown in Table 1 and Fig. 3. Specifically, in Table 1, second column, third row, the Preclinical, Total, Phase success rate (%), the entry now reading “35” initially appeared as 45%. In the Fig. 3a “Deals per series” graphic, in the slice corresponding to Series D+, the amount shown was clarified to read “$77 M.” In Fig. 3a caption, the text now reading “a, 1,050 venture financing rounds” initially read 1,051. These changes have been made to the online version of the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Bloeme, C.M., Jansen, R.W., Krul, M.R.L. et al. Author Correction: Stepping to the exit. Nat Biotechnol 39, 1597 (2021). https://doi.org/10.1038/s41587-021-01142-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-021-01142-9